Recently, Sinopharm Engineering, together with Guangdong Pharmaceutical Association, Guangdong Pharmaceutical Association Pharmaceutical Engineering Professional Committee and Guangzhou Biological Industry Alliance, organized a pharmaceutical engineering technology exchange meeting in Guangzhou. Bay Area pharmaceutical R & D and manufacturing enterprises, pharmaceutical industry experts, etc.200 more people participated in this exchange.

At the meeting, Chen Jinhui, deputy general manager of Sinopharm Engineering, made a keynote speech on "Technology Innovation, Strong Cooperation, and a New Journey of Gathering Strength and Win-Win", saying that the pharmaceutical engineering industry is facing a new situation of new economic policy changes, technological progress and people's improved health awareness brought about by the "post-epidemic era". Sinopharm Engineering Guangzhou Branch has been deeply engaged in the pharmaceutical engineering industry in Guangdong-Hong Kong-Macao Greater Bay Area for more than ten years, after the industrial transformation and development of the pharmaceutical engineering industry in South China, facing new challenges and new opportunities, we will use this exchange meeting to take "pharmaceutical engineering technology innovation" as the entry point, focus on the cutting-edge technology of pharmaceutical engineering, discuss with experts the development trend and direction of the pharmaceutical engineering industry, strengthen cooperation, seek common development, mutual benefit and win-win, and contribute to the healthy development of the pharmaceutical engineering industry.

During the exchange meeting, a number of experts from Sinoparma Engineering Headquarters and molecular companies delivered keynote speeches on their respective deep-cultivated technical fields, and conducted lively discussions in the on-site exchange link.

This exchange meeting fully demonstrated the company's strong technical strength in the entire pharmaceutical engineering industry chain, strengthened its brand influence in the pharmaceutical engineering field of the Guangdong-Hong Kong-Macao Greater Bay Area, and laid a good foundation for the company's sustainable development in the Guangdong-Hong Kong-Macao Greater Bay Area.

        ( contributions from Guangzhou Branch)